Evaluation of HIV incidence surveillance in New York City, 2006

Public Health Reports

Volumn 126, Issue 1, 2011, Pages 28-38

  Nair, Hemanth P ^a,b   Torian, Lucia V ^a   Forgione, Lisa ^a   Begier, Elizabeth M ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE SURVEILLANCE; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; UNITED STATES;

EID: 79951520803     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491112600107     Document Type: Article

References (31)

1. Hendriks JC, Satten GA, van Ameijden EJ, van Druten HA, Coutinho RA, van Griensven GJ. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis. AIDS 1998;12:1537-44. (Pubitemid 28369655)
2. Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002;16:597-603.
3. McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, Ackers M, et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006;22:945-52. (Pubitemid 46100678)
4. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes [published erratum appears in JAMA 1999;281:1893]. JAMA 1998;280:42-8.
5. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002;18:295-307. (Pubitemid 34253148)
6. McDougal JS, Pilcher CD, Parekh BS, Bershy-Damet G, Branson BM, Marsh K, et al. Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS 2005;19 Suppl 2:S25-30.
7. Des Jarlais DC, Perlis T, Arasteh K, Torian LV, Beatrice S, Milliken J, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health 2005;95:1439-44.
8. Alves K, Shafer KP, Caseiro M, Rutherford G, Falcao ME, Sucupira MC, et al. Risk factors for incident HIV infection among anonymous HIV testing site clients in Santos, Brazil: 1996-1999. J Acquir Immune Defic Syndr 2003;32:551-9.
9. de Freitas Oliveira CA, Ueda M, Yamashiro R, Rodrigues R, Sheppard HW, de Macedo Brigido LF. Rate and incidence estimates of recent human immunodeficiency virus type 1 infections among pregnant women in Sao Paulo, Brazil, from 1991 to 2002. J Clin Microbiol 2005;43:1439-42.
10. Fisher M, Pao D, Murphy G, Dean G, McElborough D, Homer G, et al. Serological testing algorithm shows rising HIV incidence in a UK cohort of men who have sex with men: 10 years application. AIDS 2007;21:2309-14. (Pubitemid 350287457)
11. Gouws E, Williams BG, Sheppard HW, Enge B, Karim SA. High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. J Acquir Immune Defic Syndr 2002;29:531-5. (Pubitemid 34456346)
12. Gupta P, Kingsley L, Sheppard HW, Harrison LH, Chatterjee R, Ghosh A, et al. High incidence and prevalence of HIV-1 infection in high risk population in Calcutta, India. Int J STD AIDS 2003;14:463-8. (Pubitemid 36819482)
13. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, et al. Estimation of HIV incidence in the United States. JAMA 2008;300:520-9.
14. Murphy G, Charlett A, Jordan LF, Osner N, Gill ON, Parry JV. HIV incidence appears constant in men who have sex with men despite widespread use of effective antiretroviral therapy. AIDS 2004;18:265-72. (Pubitemid 38253449)
15. Murphy G, Parry JV, Gupta SB, Graham C, Jordan LF, Nicoll AN, et al. Test of HIV incidence shows continuing HIV transmission in homosexual/bisexual men in England and Wales. Commun Dis Public Health 2001;4:33-7.
16. Schwarcz S, Weinstock H, Louie B, Kellogg T, Douglas J, Lalota M, et al. Characteristics of persons with recently acquired HIV infection: application of the serologic testing algorithm for recent HIV seroconversion in 10 US cities. J Acquir Immune Defic Syndr 2007;44:112-5. (Pubitemid 46052229)
17. Schwarcz SK, Kellogg TA, McFarland W, Louie B, Klausner J, Withum DG, et al. Characterization of sexually transmitted disease clinic patients with recent human immunodeficiency virus infection. J Infect Dis 2002;186:1019-22.
18. Taylor MM, Hawkins K, Gonzalez A, Buchacz K, Aynalem G, Smith LV, et al. Use of the serologic testing algorithm for recent HIV seroconversion (STARHS) to identify recently acquired HIV infections in men with early syphilis in Los Angeles County. J Acquir Immune Defic Syndr 2005;38:505-8. (Pubitemid 40524471)
19. Torian L, Forgione L, Eavey J, Kent S, Bennani Y. HIV incidence in New York City in 2006. Poster presented at the 16th Conference on Retroviruses and Opportunistic Infections; 2009 Feb 8-11; Montreal.
20. German RR, Lee LL, Horan JM, Milstein RL, Pertowski CA, Waller MN, et al. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep 2001;50(RR-13):1-35.
21. Karon JM, Song R, Brookmeyer R, Kaplan EH, Hall HI. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results. Stat Med 2008;27:4617-33.
22. Survey Monkey. SurveyMonkey™. Portland (OR): Survey Monkey; 2009.
23. SAS Institute, Inc. SAS®: Version 9.1 for Windows. Cary (NC): SAS Institute, Inc.; 2003.
24. Azaroff LS, Levenstein C, Wegman DH. Occupational injury and illness surveillance: conceptual filters explain underreporting. Am J Public Health 2002;92:1421-9. (Pubitemid 34921055)
25. Brissette I, Gelberg KH, Grey AJ. The effect of message type on physician compliance with disease reporting requirements. Public Health Rep 2006;121:703-9. (Pubitemid 46280260)
26. Konowitz PM, Petrossian GA, Rose DN. The underreporting of disease and physicians' knowledge of reporting requirements. Public Health Rep 1984;99:31-5. (Pubitemid 14146689)
27. Meek JI, Roberts CL, Smith EV Jr, Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. J Public Health Manag Pract 1996;2:61-5.
28. New York City Department of Health and Mental Hygiene. HIV epidemiology and field services seminual report. New York: NYC DOHMH; 2008. Also available from: URL: http://www.nyc.gov/html/doh/downloads/pdf/dires/dires-2008-report- semi2.pdf [cited 2010 Aug 13].
29. New York City Department of Health and Mental Hygiene. Health department releases estimate of yearly HIV infections [press release] 2008 Aug 27 [cited 2010 Aug 13]. Available from: URL: http://www.nyc.gov/html/doh/html/pr2008/ pr057-08.shtml
30. Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, Williams D, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005;352:1873-83. (Pubitemid 40627813)
31. Acute HIV infection - New York City, 2008. MMWR Morb Mortal Wkly Rep 2009;58(46):1296-9.